ANNUAL REPORT
2014
АLCOMET AD
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 25
INCOME STATEMENT
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
Notes
Year ended
December 31,
2014
Year ended
December 31,
2013
Revenue 4 293,535 279,671
Cost of sales 5 (269,026) (256,291)
Gross margin 24,509 23,380
Other income 6 7,579 6,863
Administrative expenses 7 (9,664) (9,423)
Distribution expenses 8 (11,592) (10,586)
Other expenses 9 (4,204) (4,430)
Exchange rate gain/(loss), net 11 70 (182)
Interest expenses, net 12 (3,666) (2,741)
Other financial expenses net 13 (347) (389)
Profit before taxation 2,685 2,492
Income tax expense 14 (278) (254)
Profit for the period 2,407 2,238
Earning per share (BGN) 15 0.13 0.12
Approved for issuance by the Managing Board of Alcomet AD on March 4, 2015
Huseyin Yorucu (signed)
Huseyin Umut Ince (signed) Semih Baturay (signed) Vencislav Petrov (signed)
Executive Directors Financial Director Chief Accountant
Antoaneta Bazlyankova (signed) Nadezhda Peeva-Uzunova (signed)
Managing Director Registered Auditor
AndA Consulting Ltd
March 4, 2015, Sofia
The accompanying notes are an integral part of these financial statements.
АLCOMET AD
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 26
STATEMENT OF COMPREHENSIVE INCOME
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
Notes
Year ended
December 31,
2014
Year ended
December 31,
2013
Profit for the period 2,407 2,238
Other comprehensive income
Items,that will not be reclassified subsequently
to profit or loss:
Actuarial loss, incurred during the period 25 (53) (52)
Tax effect on actuarial loss, incurred during the
period
5
5
(48) (47)
Items,that may be reclassified subsequently
to profit or loss:
Adjustment of the hedging reserve for the
loss/(gain) from forward contracts, transferred to
the initial carrying amount of the hedged items 24
1,157
(183)
Tax effect on the adjustment of the hedging reserve
for the result from forward contracts, transferred
to the initial carrying amount of the hedged items
(116)
18
Unrealized profit/(loss) on forward contracts,
recognized in the hedging reserve 24
832
(1,157)
Tax effect on the unrealized profit/(loss) on
forward contracts, recognized in the hedging
reserve 24
(83)
116
1,790
(1,206)
Total other comprehensive income for the period,
net of tax
1,742
(1,253)
TOTAL COMPREHENSIVE INCOME
FOR THE PERIOD
4,149
985
Approved for issuance by the Managing Board of Alcomet AD on March 4, 2015
Huseyin Yorucu (signed)
Huseyin Umut Ince (signed) Semih Baturay (signed) Vencislav Petrov (signed)
Executive Directors Financial Director Chief Accountant
Antoaneta Bazlyankova (signed) Nadezhda Peeva-Uzunova (signed)
Managing Director Registered Auditor
AndA Consulting Ltd
March 4, 2015, Sofia
The accompanying notes are an integral part of these financial statements.
АLCOMET AD
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 27
STATEMENT OF FINANCIAL POSITION
as of December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
Notes
December 31,
2014
December 31,
2013
ASSETS
Non-current assets
Property, plant and equipment 16 113,662 119,797
Intangible assets 17 340 540
Investment property 18 4,935 4,935
Financial assets 19 5,650 5,500
Deferred tax assets 14 201 419
124,788 131,191
Current assets
Inventories 20 60,400 46,694
Trade and other receivables, net 21 53,127 48,133
Derivative financial instruments 24 879 -
Cash and cash equivalents 22 4,709 733
119,115 95,560
TOTAL ASSETS 243,903 226,751
EQUITY AND LIABILITIES
Capital and reserves
Share capital 23 17,953 17,953
Legal reserve 23 1,795 1,795
Revaluation reserve 23 55,830 56,145
Hedging reserve 23 749 (1,041)
Retirement benefits obligation reserve 23 (922) (874)
Accumulated profit 23,693 21,531
99,098 95,509
Non-current liabilities
Retirement benefits obligation 25 884 1,048
Long-term borrowings 26 20,412 26,184
Derivative financial instruments 24 - 27
Deferred income 27 1,882 -
Deferred tax liabilities 14 4,119 4,555
27,297 31,814
Current liabilities
Trade and other payables 28 21,294 13,120
Short-term borrowings 26 95,409 84,111
Deferred income 27 128 -
Derivative financial instruments 24 - 1,157
Income tax liability 29 41 235
Accruals 30 636 805
117,508 99,428
TOTAL EQUITY AND LIABILITIES 243,903 226,751
Approved for issuance by the Managing Board of Alcomet AD on March 4, 2015
Huseyin Yorucu (signed)
Huseyin Umut Ince (signed) Semih Baturay (signed) Vencislav Petrov (signed)
Executive Directors Financial Director Chief Accountant
Antoaneta Bazlyankova (signed) Nadezhda Peeva-Uzunova (signed)
Managing Director, AndA Consulting Ltd. Registered Auditor
March 4, 2015, Sofia
The accompanying notes are an integral part of these financial statements.
АLCOMET AD
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 28
CASH FLOW STATEMENT
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
Year ended
December 31,
2014
Year ended
December 31,
2013
Cash flows from operating activities
Profit before taxation 2,685 2,492
Adjustments for:
Depreciation of property, plant and equipment 11,619 9,820
Amortization of intangible assets 200 161
Loss on disposal of property, plant and equipment 6 -
Carrying amount of obsolete property, plant and equipment 1 -
Receivables and payables written-off, net 95 616
Income from government grants (47) -
Income from dealing with securities - (53)
Interest expense, net 3,666 2,741
Changes in accruals and retirement benefits obligation (428) (148)
Exchange rate loss 136 106
17,933 15,735
Increase in inventory (13,706) (7,079)
Increase in current accounts receivable (5,119) (5,244)
Increase/(decrease) in current liabilities 8,170 (1,818)
Cash, generated from operating activities
7,278 1,594
Interest received 8 1
Interest paid (4,114) (3,217)
Income tax paid (884) (109)
Dividends paid (559) (582)
Net cash, (used in)/generated fromoperating activities 1,729 (2,313) Cash flows from investing activities
Purchase of property, plant and equipment and intangible assets (5,427) (9,987) Government grants 2,057 - Proceeds from sales of property, plant and equipment 21 -
Net cash used in investing activities (3,349) (9,987) Cash flows from financing activities
Proceeds from borrowings 698,323 650,852
Repayments of borrowings (689,704) (635,686)
Payments of finance lease obligations (2,835) (2,695) Net cash, generated from financing activities 5,784 12,471
Net increase in cash and cash equivalents 4,164 171
Cash and cash equivalents at the beginning of the period 509 338
Cash and cash equivalents at the end of the period (see note 22) 4,673 509
Approved for issuance by the Managing Board of Alcomet AD on March 4, 2015
Huseyin Yorucu (signed)
Huseyin Umut Ince (signed) Semih Baturay (signed) Vencislav Petrov (signed)
Executive Directors Financial Director Chief Accountant
Antoaneta Bazlyankova (signed) Nadezhda Peeva-Uzunova (signed)
Managing Director Registered Auditor
AndA Consulting Ltd
March 4, 2015, Sofia
The accompanying notes are an integral part of these financial statements.
АLCOMET AD
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 29
STATEMENT OF CHANGES IN EQUITY
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
Share
capital Reserves
Accumulated
profit Total
Balance at December 31, 2012 17,953 57,278 19,876 95,107
Changes in equity for 2013
Dividends - - (583) (583)
Comprehensive income for the
period - (1,253) 2,238 985
Balance at December 31, 2013 17,953 56,025 21,531 95,509
Changes in equity for 2014
Dividends - - (560) (560)
Revaluation reserve of obsolete
property, plant and equipment - (315) 315 -
Comprehensive income for the
period - 1,742 2,407 4,149
Balance at December 31, 2014 17,953 57,452 23,693 99,098
Approved for issuance by the Managing Board of Alcomet AD on March 4, 2015
Huseyin Yorucu (signed)
Huseyin Umut Ince (signed) Semih Baturay (signed) Vencislav Petrov (signed)
Executive Directors Financial Director Chief Accountant
Antoaneta Bazlyankova (signed) Nadezhda Peeva-Uzunova (signed)
Managing Director Registered Auditor
AndA Consulting Ltd
March 4, 2015, Sofia
The accompanying notes are an integral part of these financial statements.
АLCOMET AD
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 30
NOTES TO THE FINANCIAL STATEMENTS
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
1 General information
1.1 Organization
Alcomet AD (the Company) is a joint-stock company registered in Bulgaria in 1991. The Company
is entered in the Trade Register of the Registry Agency under Unified Identification Code
837066358. The address of the Company’s principal place of business and head office is Shumen,
Second Industrial Zone.
Alcomet AD is a public company, registered in the Public Companies Register, as per decision of
the Financial Supervision Commission dated July 1, 1998. The Company’s shares are traded on the
Bulgarian Stock Exchange, Sofia.
The Company was established under the name of Alumina EAD and the sole shareholder of the
Company was the Government of Bulgaria. On September 13, 1999 the Privatization Agency sold
1,116,361 shares of the Company to private investors, which presented 75 % of the share capital of
the Company.
As of December 31, 2014 and 2013 the structure of the share capital of the Company is as follows:
December 31,
2014
December 31,
2013
Alumetal AD 73.25% 73.25%
FAF Metal Sanayj Ve Ticaret AS, Turkey 16.86% 16.86%
ZUPF Allianz Bulgaria 3.59% 2.94%
Other 6.30% 6.95%
Total 100.00% 100.00%
1.2 Operations
The main operations of the Company include production and sale of castings, rolled and extruded
aluminum products, used in machine building, construction, food industry, etc. The Company is the
leading Bulgarian producer of aluminum products and one of the largest manufacturers on the
Balkans. The plant is unique in Bulgaria as it includes entire production cycle and by the modern
technological equipment of the three main workshops - casting, rolling and extrusion, produces a
wide range of rolled and extruded products, which technical parameters and quality conform to the
international standards ISO 9001:2008, ISO 14000:2004, OHSAS 18000:2007, AA , EN, DIN, BDS.
The annual production capacity of the casting workshop is 78 thousand tons, rolling workshop -
50 thousand tons and extrusion workshop - 23 thousand tons.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 31
2 Basis for preparation of the financial statements
2.1 Financial reporting framework
The Company prepares and presents its financial statements in accordance with the International
Financial Reporting Standards (IFRS), issued by the International Accounting Standards Board
(IASB) and the Interpretations, issued by the International Financial Reporting Interpretations
Committee (IFRIC), adopted by the European Union Commission (the Commission).
During the current year the Company has adopted all new and revised standards and interpretations
issued by the International Accounting Standards Board (IASB), effective for 2014 and applicable for
the activities of the Company. All changes in IFRS, effective for 2014, are approved by the
Commission (see note 2.1.1).
These financial statements are prepared for general purpose and provide information for the financial
position, results and cash flows, generated by the Company for the year ended December 31, 2014.
2.1.1 Standards and Interpretations effective in the current period
The following amendments to the existing standards and interpretations are adopted by the EU
Comission and are effective for 2014:
Standard or interpretation, date of
revision and effective date
Name of the standard or
interpretation
Effect on the Company’s
activity
Transition guidance (Amendments to
IFRS 10, IFRS 11 and IFRS 12), issued
in June 2012, effective for annual
periods beginning on or after
January 1, 2014
Transition guidance No effect on the Company’s
financial statements
IFRS 10, issued in May 2011, effective
for annual periods beginning on or after
January 1, 2013, but applied in the EU
after January 1, 2014
Consolidated Financial Statements No effect on the Company’s
financial statements
IFRS 11, issued in May 2011, effective
for annual periods beginning on or after
January 1, 2013, but applied in the EU
after January 1, 2014
Joint Arrangements No effect on the Company’s
financial statements
IFRS 12, issued in May 2011, effective
for annual periods beginning on or after
January 1, 2013, but applied in the EU
after January 1, 2014
Disclosure of Interests in Other
Entities
No effect on the Company’s
financial statements
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 32
2 Basis for preparation of the financial statements (continued)
2.1 Financial reporting framework (continued)
2.1.1 Standards and Interpretations effective in the current period (continued)
Standard or interpretation, date of
revision and effective date
Name of the standard or
interpretation
Effect on the Company’s
activity
IAS 27, issued in May 2011, effective
for annual periods beginning on or after
January 1, 2013, but applied in the EU
after January 1, 2014
Separate Financial Statements No effect on the Company’s
financial statements
IAS 28, issued in May 2011, effective
for annual periods beginning on or after
January 1, 2013, but applied in the EU
after January 1, 2014
Investments in Associates and Joint
Ventures
No effect on the Company’s
financial statements
Amendments to IAS 32, issued in
December 2011, effective for annual
periods beginning on or after
January 1, 2014
Financial Instruments: Presentation
— Amendments to application
guidance on the offsetting of
financial assets and financial
liabilities
No effect on the Company’s
financial statements
Amendments to IFRS 10, IFRS 12 and
IAS 27, issued in October 2012,
effective for annual periods beginning on
or after January 1, 2014
Amendments to IFRS 10, IFRS 12
and IAS 27: Investment entities
No effect on the Company’s
financial statements
Amendments of IAS 36, issued on May
29, 2013, effective for annual periods
beginning on or after January 1, 2014
Amendments to IAS 36, related to
recoverable amount disclosures of
non-financial assets
No effect on the Company’s
financial statements
Amendments of IAS 39, issued on June
27, 2013, effective for annual periods
beginning on or after January 1, 2014
Amendments of IAS 39, related to
novation of derivatives and
continuation of hedge accounting
No effect on the Company’s
financial statements
IFRIC interpretation 21 Levies, issued on
May 20, 2013, effective for annual
periods beginning on or after January 1,
2014
IFRIC interpretation No effect on the Company’s
financial statements
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 33
2 Basis for preparation of the financial statements (continued)
2.1 Financial reporting framework (continued)
2.1.2 Standards and Interpretations, issued by the International Accounting Standards Board (IASB),
adopted by the Commission, not yet effective
Standard or interpretation, date of
revision and effective date
Name of the standard or
interpretation
Date of adoption
by the EU Commission
Annual Improvements 2010-2012
Cycle, issued by the IASB on
December 12, 2013, applicable to
annual periods beginning on or after
July 1, 2014
Improvements to IFRS
(IFRS 2, IFRS 3, IFRS 8, IFRS
13, IAS 16, IAS 24 and
IAS 38)
December 17, 2014
Annual Improvements 2011-2013
Cycle, issued by the IASB on
December 12, 2013, applicable to
annual periods beginning on or after
July 1, 2014
Improvements to IFRS
(IFRS 1, IFRS 3, IFRS 13 and
IAS 40)
December 18, 2014
Defined Benefit Plans: Employee
Contributions issued on November 21,
2013, effective for annual periods
beginning on or after July 1, 2014
Amendments to IAS 19 December 17, 2014
2.1.3 Standards and Interpretations, issued by the IASB, expected endorsement by the EU Commission
Standard or interpretation, date of
revision and effective date
Name of the standard or
interpretation
Status of adoption
by the EU Commission
IFRS 9 Financial Instruments (issued on
July 24, 2014), effective for annual
periods beginning on or after
January 1, 2018
Financial Instruments –
Classification and Measurement,
the standard will supersede
completely IAS 39
Endorsement expected in
the second half of 2015
IFRS 14, issued in January, 2014,
effective for annual periods beginning on
or after January 1, 2016
Regulatory Deferral Accounts -
applicable to an entity's first annual
IFRS financial statements for a
period beginning on or after
January 1, 2016
The endorsement date is yet
to be determined
IFRS 15, issued in May, 2014, effective
for annual periods beginning on or after
January 1, 2017
Revenue from Contracts with
Customers - applicable to an
entity's first annual IFRS financial
statements for a period
beginning on or after
January 1, 2017
Endorsement is expected
in Q 2 2015
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 34
2 Basis for preparation of the financial statements (continued)
2.1 Financial reporting framework (continued)
2.1.3 Standards and Interpretations, issued by the IASB, expected endorsement by the EU Commission
(continued)
Standard or interpretation, date of
revision and effective date
Name of the standard or
interpretation
Status of adoption
by the EU Commission
Amendments to IFRS 10, IFRS 12 and
IAS 28 (issued on December 18,
2014), effective for annual periods
beginning on or after January 1, 2016
Investment Entities: Applying the
Consolidation Exception
Endorsement is expected
in Q 4 2015
Amendments to IAS 1 (issued on
December 18, 2014), effective for
annual periods beginning on or after
January 1, 2016
Disclosure Initiative Endorsement is expected
in Q 4 2015
Annual Improvements 2012-2014
Cycle, issued by the IASB on
September 25, 2014, applicable to
annual periods beginning on or after
January 1, 2017
Improvements to IFRS
(IFRS 5, IFRS 7, IAS 19 and IAS
34)
Endorsement is expected
in Q 3 2015
Amendments to IFRS 10 and IAS 28,
issued on September 11, 2014,
effective for annual periods beginning
on or after January 1, 2016
Amendments to IFRS 10 and IAS
28: Sale or Contribution of Assets
between an Investor and its
Associate or Joint Venture
Endorsement is expected
in Q 4 2015
Amendments to IAS 27, issued on
August 12, 2014, effective for annual
periods beginning on or after
January 1, 2016
Amendments to IAS 27: Equity
Method in Separate Financial
Statements
Endorsement is expected
in Q 3 2015
Amendments to IAS 16 and IAS 41,
issued on June 30, 2014, effective for
annual periods beginning on or after
January 1, 2016
Amendments to IAS 16 and IAS
41: Bearer Plants
Endorsement is expected
in Q 1 2015
Amendments to IAS 16 and IAS 38,
issued on May 12, 2014, effective for
annual periods beginning on or after
January 1, 2016
Amendments to IAS 16 and IAS
38: Clarification of Acceptable
Methods of Depreciation and
Amortization
Endorsement is expected
in Q 1 2015
Amendments to IFRS 11, issued on
May 6, 2014, effective for annual
periods beginning on or after
January 1, 2016
Amendments to IFRS 11:
Accounting for Acquisitions of
Interests in Joint Operations
Endorsement is expected
in Q 1 2015
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 35
2 Basis for preparation of the financial statements (continued)
2.1 Financial reporting framework (continued)
2.1.4 Impact of the new and revised standards on the financial statements
In the current year, the Company has applied a number of amendments to IFRSs and a new
Interpretation issued by the International Accounting Standards Board (IASB) that are mandatorily
effective for an accounting period that begins on or after 1 January 2014.
The more significant changes in the accounting standards are, as follows:
IFRS 10 Consolidated Financial Statements
The objective of IFRS 10 is to establish principles for the presentation and preparation of consolidated
financial statements when an entity controls one or more other entities. IFRS 10 is a replacement of
IAS 27 Consolidated and Separate Financial Statements and SIC-12 Consolidation – Special Purpose
Entities. Concurrent with the issuance of IFRS 10, the IASB also issued:
IFRS 11 Joint Arrangements;
IFRS 12 Disclosure of Interests in Other Entities;
IAS 27 Separate Financial Statements (reissued in 2011), and
IAS 28 Investments in Associates and Joint Ventures (reissued in 2011).
These amendments do not affect the Company, as it does not prepare consolidated financial
statements (see also noe 19) and has no any and not planned undertaking of engagements for joint
ventures.
Amendments to IFRS 10, IFRS 12 and IAS 27 Investment Entities
The Company has applied the amendments to IFRS 10, IFRS 12 and IAS 27 regarding investment
entities for the first time in the current year. The amendments to IFRS 10 define an Investment entity
and require a reporting entity that meets the definition of an Investment entity not to consolidate its
subsidiaries but instead to measure its subsidiaries at fair value through profit or loss in its
consolidated and separate financial statements.
To qualify as an “investment entity”, a reporting entity is required to:(i) obtain funds from one or
more investors for the purpose of providing them with investment management services; (ii) commit
to its investor(s) that its business purpose is to invest funds solely for returns from capital
appreciation, investment income, or both; and (iii) measure and evaluate performance of substantially
all of its investments on a fair value basis.
http://www.iasplus.com/standard/ifrs11.htmhttp://www.iasplus.com/standard/ifrs12.htmhttp://www.iasplus.com/standard/ias28_2011.htm
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 36
2 Basis for preparation of the financial statements (continued)
2.1 Financial reporting framework (continued)
2.1.4 Impact of the new and revised standards on the financial statements (continued)
Amendments to IFRS 10, IFRS 12 and IAS 27 Investment Entities (continued)
Consequential amendments have been made to IFRS 12 and IAS 27 to introduce new disclosure
requirements for Investment entitles.
As the Company is not an investment entity (assessed based on the criteria set out in IFRS 10 as at
January 1, 2014), the application of the amendments has had no impact on the disclosures or the
amounts recognised in the Company’s financial statements.
Amendments to IAS 32 Offsetting Financial Assets and Financial Liabilities
The Company has applied the amendments to IAS 32 regarding offsetting financial assets and
financial liabilities for the first time in the current year. The amendments to IAS 32 clarify the
requirements relating to the offset of financial assets and financial liabilities. Specifically, the
amendments clarify the meaning of “currently has a legally enforceable right of set-off” and
“simultaneous realisation and settlement”.
The amendments have been applied retrospectively. As the Company does not have any financial
assets and financial liabilities that qualify for offset, the application of the amendments has had no
impact on the disclosures or on the amounts recognised in the Company’s financial statements.
Amendments to IAS 36 Recoverable Amount Disclosures for Non-financial Assets
The Company has applied the amendments to IAS 36 regarding recoverable amount disclosures for
non-financial assets for the first time in the current year. The amendments to IAS 36 remove the
requirement to disclose the recoverable amount of a cash-generating unit (CGU) to which goodwill or
other intangible assets with indefinite useful lives had been allocated when there has been no
impairment or reversal of impairment of the related CGU.
Furthermore, the amendments introduce additional disclosure requirements applicable to when the
recoverable amount of an asset or a CGU is measured at fair value less costs of disposal. These new
disclosures include the fair value hierarchy, key assumptions and valuation techniques used which are
in line with the disclosure required by IFRS 13 Fair Value Measurements.
The application of these amendments has had no material impact on the disclosures in the Company’s
financial statements.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 37
2 Basis for preparation of the financial statements (continued)
2.1 Financial reporting framework (continued)
2.1.4 Impact of the new and revised standards on the financial statements (continued)
Amendments to IAS 39 Novation of Derivatives and Continuation of Hedge Accounting
The Company has applied the amendments to IAS 39 regarding novation of derivatives and
continuation of hedge accounting for the first time in the current year. The amendments to IAS 39
provide relief from the requirement to discontinue hedge accounting when a derivative designated as a
hedging instrument is novated under certain circumstances. The amendments also clarify that any
change to the fair value of the derivative designated as a hedging instrument arising from the novation
should be included in the assessment and measurement of hedge effectiveness.
The amendments have been applied retrospectively. As the Company does not have any derivatives
that are subject to novation, the application of these amendments has had no impact on the disclosures
or on the amounts recognised in the Company’s financial statements.
IFRIC 21 Levies
The Company has applied IFRIC 21 Levies for the first time in the current year. IFRIC 21 addresses
the issue as to when to recognise a liability to pay a levy imposed by a government. The interpretation
defines a levy, and specifies that the obligating event that gives rise to the liability is the activity that
triggers the payment of the levy, as identified by legislation. The interpretation provides guidance on
how different levy arrangements should be accounted for, in particular, it clarifies that neither
economic compulsion nor the going concern basis of financial statements preparation implies that an
entity has a present obligation to pay a levy that will be triggered by operating in a future period.
IFRIC 21 has been applied retrospectively. The application of this Interpretation has had no material
impact on the disclosures or on the amounts recognised in the Company’s financial statements.
During 2014 the Company has not elected early adoption of standards, revisions and interpretations,
effective for future annual periods. The Company anticipates that the adoption of the standards,
amendments to the existing standards and interpretations would have no material impact on its
financial statements in the period of initial application, except for IFRS 9, the impact of which has not
yet been evaluated.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 38
2. Basis for preparation of the financial statements (continued)
2.2 Historical cost and fair value
The present financial statements have been prepared on the historical cost basis except for certain
property, plant and equipment, investment property and derivative financial instruments that are
measured at revalued amounts or fair values, as explained in notes 3.7, 3.9 and 3.12 below.
Historical cost is generally based on the fair value of the consideration given in exchange for goods
and services.
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date, regardless of whether that price is
directly observable or estimated using another valuation technique. In estimating the fair value of an
asset or a liability, the Company takes into account the characteristics of the asset or liability if market
participants would take those characteristics into account when pricing the asset or liability at the
measurement date. Fair value for measurement and/or disclosure purposes in these financial
statements is determined on such a basis, except for share-based payment transactions that are within
the scope of IFRS 2, leasing transactions that are within the scope of IAS 17, and measurements that
have some similarities to fair value but are not fair value, such as net realizable value in IAS 2 or
value use in IAS 36.
In addition, for the financial reporting purposes, fair value measurements are categorized into Level 1,
2 or 3 based on the degree to which the inputs to the fair value measurements are observable and the
significance of the inputs to the fair value measurement in its entirely, which are described as follows:
- Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities
that the Company can access at the measurement date;
- Level 2 inputs are inputs, other than quoted prices included within Level 1, that are observable
for the asset or liability, either directly or indirectly;
- Level 3 inputs are unobservable inputs for the asset or liability.
2.3 Functional and presentation currency
Functional currency is the currency of the primary economic environment, in which an entity operates
and in which it generates and expends cash. The entity carries out its transactions mainly in Bulgarian
Lev, and for this reason the functional and presentation currency is the Bulgarian Lev, which since
January 1, 1999 has been pegged to the EURO at a fixed exchange rate of EUR 1: BGN 1.95583.
These financial statements are presented in thousands of BGN.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 39
3 Significant accounting policies
3.1 Revenue and expense recognition
Revenue is measured at the fair value of the consideration received or receivable and represents
amounts receivable for goods and services provided in the normal course of business, net of discounts,
Value Added Tax (VAT) and other sales related taxes.
Revenue is recognized when the entity has transferred all risks and rewards related to the ownership
of the production and goods to the buyer and the costs incurred in respect of the transaction can be
measured reliably.
Expenses are recognized in the income statement when a decrease of the future economic benefits
arise, regarding decrease of an asset or increase of a liability, which can be reliably measured.
Expenses are recognized on the basis of a direct association between the costs incurred and the revenue.
When economic benefits are expected to incur during more than one financial period and the
corresponding revenue cannot be measured precisely but only indirectly, the expenses shall be
recognized based on procedures for rational and systematic allocation.
Income from government grants related to assets is recognized in profit or loss on a systematic basis
over the whole useful lives of the related assets (see also note 3.14).
3.2 Interest income
Interest income is accrued on a time basis, based on the outstanding principal and the applicable
effective interest rate, which is the rate that exactly discounts estimated future cash receipts through
the expected life of the financial asset to the net carrying amount of the asset.
3.3 Borrowing costs
Borrowing costs are recognized in the period in which they are incurred and are determined on the
basis of the outstanding principal and the applicable effective interest rate, which is the rate that
exactly discounts estimated future cash payments through the expected life of the financial liability to
the net carrying amount of the liability.
Borrowing costs that are directly attributable to the acquisition, construction or production of an asset,
that takes a substantial period of time to get ready for its intended use or sale, are capitalized as part of
the cost of the asset in accordance with the requirements of IAS 23 Borrowing costs. The borrowing
costs that are directly attributable to the acquisition or production of a qualifying asset are those
borrowing costs that would have been avoided, if the expenditure on the qualifying asset had not been
made.
The amount of borrowing costs eligible for capitalization is determined as the actual borrowing costs
incurred on the borrowings during the period less any investment income on the temporary investment
of those borrowings. To the extent that funds are borrowed generally and used for the purpose of
obtaining a qualifying asset, the amount of borrowing costs eligible for capitalization is determined by
applying a capitalization rate to the expenditures on that asset. The capitalization rate is the weighted
average of the borrowing costs applicable to the borrowings that are outstanding during the period.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 40
3 Significant accounting policies (continued)
3.3 Borrowing costs (continued)
Investment income earned on the temporary investment of specific borrowings pending their
expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalization. All
other borrowing costs are recognized in profit or loss in the period in which they are incurred.
Capitalization of borrowing costs ceases when substantially all the activities necessary to prepare the
qualifying asset for its intended use are complete.
3.4 Foreign currency
Foreign currency transactions are recorded at the rates of exchange prevailing on the dates of the
transactions. At the end of each reporting period, monetary assets and liabilities that are denominated
in foreign currencies are retranslated at the closing exchange rates of the Bulgarian National Bank.
The foreign exchange rate differences, arising upon the settlement of these monetary positions or at
restatement of these positions at rates, different from those when initially recorded, are reported as
current financial income or current financial expense in the period in which they arise.
3.5 Employee benefits
Short-term employee benefits
Labor and social relationships between the employees and the Company are arranged under the
provisions of the Labour Code (LC) and the social security legislation requirements enforceable in the
Republic of Bulgaria.
Short-term employee benefits including remunerations, bonuses and social payments and benefits
(payable within 12 months after the period in which employees have rendered their service or satisfied
the necessary conditions) are recognized as an expense in the income statement for the period in
which the service is rendered or the vesting conditions are met, and as a current liability (after
reduction of any amounts paid and deductions) to its undiscounted amount. The Company’s
contributions for social security and health insurance are recognized at their undiscounted amount as
current expense and liability together with and for the period, when the respective employee benefits
are accrued.
Unused paid annual leaves accruals
As of the reporting period end, the Company recognizes as a liability the non-discounted amount of
the estimated expenses on paid leaves, expected to be paid to employees during following reporting
periods as compensation to their labor in the previous reporting period, as well as the respective to
these accruals expenses on social security contributions.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 41
3 Significant accounting policies (continued)
3.5 Employee benefits (continued)
Long-term employee benefits
Defined contributions plan
The Bulgarian government has responsibility to ensure retirement benefits based on definite
contributions. Expenses, concerning the Company’s responsibility to transfer installments on the
definite contributions plan, are recognized in the income statement for the period in which they arise.
Additionally, the Company takes part in a defined contributions plan, which is a retirement plan. The
Company pays additional defined contributions to an independent company (pension fund) in favor of
the employees, included in the plan and has no legal or constructive obligation to pay additional
contributions in case the fund has insufficient assets to pay all employees the compensations,
regarding their length of service from the current or previous periods. The Company’s contributions
for this definite contributions plan are reported in the income statement for the respective period and
are included in employee benefits.
Defined benefits plan
Under the provisions of the Labor Code, the employees are entitled to retirement benefits amounting
to two gross monthly salaries on attainment of retirement age if the accumulated length of service in
the Company is under 10 years, or six gross monthly salaries if the length of service in the Company
is over 10 consecutive years.
Additionally, on early retirement due to disability, the employees are entitled to benefits amounting to
two monthly salaries, provided that their length of service is at least five years, and they have received
no other such benefits during the last five years of service. Based on the Company’s Collective Labor
Agreement dated 2006, the employees that due to disease are disabled to perform the work assigned
and in case of length of service over ten consecutive years, are entitled to an additional benefit from
the Company, amounting to one minimal monthly salary determined for the country.
In accordance with requirements of IAS 19 Employee benefits, the Company recognizes a retirement
benefits liability, which is determined estimated by a licensed actuary using the Projected Unit Credit
Method. The retirement benefits liability presents the present value of the defined retirement benefits
liability as of the date of the statement of financial position. The present value of the defined liability
is estimated based on the expected future cash outflows, using the interest rate of the government
bonds, which have a maturity term similar to the maturity of the respective liability.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 42
3 Significant accounting policies (continued)
3.5 Employee benefits (continued)
Defined benefits plan (continued)
By the use of the Projected Unit Credit Method:
• is determined what portion of the benefits is attributable to the current period and the portion
for previous periods, and estimates are made (actuarial assumptions) about demographic
variables (such as employee turnover and mortality of employees) and financial variables (such
as future increases in salaries and expenses on medical services) that will affect the cost of the
benefits;
• so defined benefits are discounted to determine the present value of the obligation for defined
benefits and the expenses for current service cost;
The current and past service costs and the interest on the liability of the defined benefits plan are
recognized in profit or loss for the period.
Revaluations of liabilities on the defined benefits plan (actuarial gain or loss) are recognized through
other comprehensive income in equity as a reserve for retirement benefits liabilities. Released from
this reserve amounts are transferred through other comprehensive income to retained earnings.
Pension costs are charged or reflected in profit or loss for the period of service of the respective
employees. Past service costs are recognized immediately to the extent that the benefits are already
vested.
The amount of the retirement benefits obligation, reported in the statement of the financial position
represents the present value of the defined benefits obligation of the Company.
3.6 Taxation
According to the Bulgarian tax legislation, the Company is subject to corporate income tax. The
corporate income tax rate for 2014 and 2013 is 10 % on the taxable profit.
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on the taxable profit for the year. Taxable profit differs from profit
before taxes as reported in the income statement because it excludes items of income or expenses that
are taxable or deductible in other years and it further excludes items that are never taxable or
deductible. The Company’s liability for current tax is calculated using tax rates that have been enacted
by the end of the reporting period.
Deferred tax is the tax expected to be payable or recoverable on differences between the carrying
amounts of assets and liabilities in the financial statements and the corresponding tax bases used in
the computation of taxable profit, and is accounted for using the balance sheet liability method.
Deferred tax liabilities are generally recognized for all taxable temporary differences and deferred tax
assets are recognized to the extent that it is probable that taxable profits will be available, against
which deductible temporary differences can be utilized.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 43
3 Significant accounting policies (continued)
3.6 Taxation (continued)
The carrying amount of deferred tax assets is reviewed at the end of each year and reduced to the
extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of
the asset to be recovered.
Furthermore at the end of each reporting period deferred tax assets not-recognized in previous
reporting periods are reviewed. Such assets are recognized to the extent that it is probable to generate
sufficient taxable profit in future, against which the deferred tax assets to be recovered.
Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is
settled or the asset realized. Deferred tax is recognized charged or credited in the income statement,
except when it relates to items charged or credited directly to equity, in which case the deferred tax is
also dealt with in equity.
Deferred tax assets and liabilities are offset when they relate to income taxes levied by the same
taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.
3.7 Property, plant and equipment
Property, plant and equipment are initially carried at cost, including purchase cost and any related
costs, less any subsequently accumulated depreciation and any impairment losses.
After initial recognition, land, buildings, plants and equipment are stated at their revalued amounts,
being the fair value at the date of revaluation, less any subsequent accumulated depreciation and
subsequent accumulated impairment losses. Revaluations are performed by licensed appraisers with
sufficient regularity so that the carrying amounts do not differ materially from that which would be
determined using fair values at the end of each reporting period.
Increases in the carrying amount of assets as a result of the revaluation are credited directly to equity
as a revaluation surplus. Decreases in carrying amounts of assets as a result of the revaluation are
recognized as expenses. However, a revaluation decrease is debited directly to revaluation reserve to
the extent that the decrease does not exceed the amount held in the revaluation surplus in respect of
those assets. The accumulated depreciation of revalued assets at the date of the revaluation is restated
proportionally with the change in the gross carrying amount of the assets, so that the carrying amount
of the assets after the revaluation equals the revalued amount.
On subsequent disposal of a revalued property, plant and equipment the attributable revaluation
surplus remaining in the revaluation reserve is transferred to retained earnings, net of deferred taxes.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 44
3 Significant accounting policies (continued)
3.7 Property, plant and equipment (continued)
At the end of each reporting period, the management of the Company reviews the carrying amounts of
property, plant and equipment, which have not been valuated by a licenced appraiser and determines
whether there is any indication for impairment of these assets.
Land and buildings, which are held to earn rentals are presented as investment property (see also note
3.9 and note 18).
The depreciation charge starts after putting the respective assets into operation and commences on the
earlier of their date of reclassification as held for sale, as required by IFRS 5 Non-current assets held
for sale and discontinued operations and their date of disposal.
Depreciation of property, plant and equipment is charged over their estimated useful lives under the
straight-line method. The estimated useful lives of the assets in years are, as follows:
2014 2013
Buildings 25 - 30 25 - 30
Plant and equipment 5 - 17 5 - 17
Vehicles 10 10
Office equipment 6-7 6-7
Other non-current assets 5 5
Assets held under finance leases are depreciated over their expected useful lives on the same basis as
owned assets. However, when there is no reasonable certainty that ownership will be obtained by the
end of the lease term, assets are depreciated over the shorter of the lease term and their useful lives.
Depreciation is not provided for land, fully depreciated assets and assets in process of acquisition or
construction.
Assets are derecognized upon disposal or when no future economic benefits are expected to arise from
the continued use of the asset. The gain or loss arising on the disposal or retirement of an asset is
determined as the difference between the sales proceeds and the carrying amount of the asset and is
recognized in the income statement.
3.8 Intangible assets
Intangible assets are carried at cost less accumulated amortization and any subsequent impairment
losses.
Amortization of intangible assets is charged over their estimated useful lives, under the straight-line
method, which period is from 2 to 7 years.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 45
3 Significant accounting policies (continued)
3.8 Intangible assets (continued)
European Union Emissions Trading Scheme and emission reduction units of greenhouse gases
The EU Allowances (EUA), received under the National Plan for allocation of allowances for trade
with emissions of greenhouse gases, are reported as intangible assets. Upon their initial acquisition,
the allocated allowances for emissions of greenhouse gases are recognized as intangible assets at
nominal value (zero value). The purchased allowances are recognized upon their acquisition at
purchase price. The allowances for emissions of greenhouse gases are not depreciated.
As at the end of each reporting period, for the amount of greenhouse gases emitted during the period
over the available distributed and purchased allowances, the Company recognizes a liability in the
statement of financial position. The liability is valued at cost of the allowances purchased, used to
cover the excess and on market prices as at the date of the statement of financial position for the
excess over the available allowances, as the liability amount and the changes therein are recognized in
profit or loss for the reporting period.
3.9 Investment property
Investment property is property held to earn rentals and is carried at fair value. As a part of property,
plant and equipment of the Company, investment properties are revaluated to their fair value by
licensed appraisers to the date of their classification as investment property. If an asset’s carrying
amount is increased as a result of such revaluation, the increase is credited directly to equity as
revaluation surplus.
The revaluation decrease is recognized in the income statement or is debited directly to equity as
revaluation surplus to the extent of any credit balance existing in the revaluation surplus in respect of
that asset. After transfer of assets to investment property, subsequent gains or losses from changes in
fair value are recognized in the net profit for the period when they arise.
An investment property is derecognized upon disposal or when the investment property is
permanently withdrawn from use and no future economic benefits are expected from the disposal.
Any gain or loss arising on derecognition of the property is calculated as the difference between the
disposal proceeds and the carrying amount of the asset and is included in the income statement.
Rental income from operating leases is recognised on a straight-line basis over the term of the relevant
lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the
carrying amount of the leased asset and recognised on a straight-line basis over the lease term.
3.10 Impairment of property, plant and equipment, intangible assets and investment property
At the end of the reporting period, the Company reviews the carrying amounts of its property, plant
and equipment, intangible assets and investment property to determine whether there is any indication
of impairment. If any such indication exists, the recoverable amount of the asset is estimated in order
to determine the extent of the impairment loss. Where the recoverable amount of an asset cannot be
reliably measured, the Company estimates the recoverable amount of the cash-generating unit, to
which the asset belongs.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 46
3 Significant accounting policies (continued)
3.10 Impairment of property, plant and equipment, intangible assets and investment property
(continued)
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in
use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate
that reflects current market assessments of the time value of money and the risks specific to the asset
for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying
amount, the carrying amount of the asset (cash-generating unit) is reduced to its recoverable amount.
The impairment loss is recognized as expense immediately, unless the relevant asset is carried at a
revalued amount, in which case the impairment loss is treated as a revaluation decrease.
When an impairment loss is subsequently reversed, the carrying amount of the asset (cash-generating
unit) is increased to the revised estimate of its recoverable amount, so that the increased carrying
amount does not exceed the carrying amount that would have been determined, had no impairment
loss been recognized for the asset (cash-generating unit) in prior years. A reversal of an impairment
loss is recognized as income immediately, unless the relevant asset is carried at a revalued amount, in
which case the reversal of the impairment loss is treated as a revaluation increase.
3.11 Inventories
Inventories are valued at the lower of cost and net realizable value. Cost comprises of all costs of
purchase, transportation, customs duties and other related costs.
Net realizable value represents the estimated selling price less all estimated costs of completion and
costs to sell.
The costs of conversion of inventories include costs directly attributable to the units of production.
They also include a systematic allocation of fixed and variable production overheads that are incurred
in converting materials into finished goods. The costs of conversion of each product, which are not
separately identifiable, are allocated between the products on a rational and consistent basis.
Assignment of the cost is determined on a weighted average basis.
3.12 Financial instruments
Financial assets and financial liabilities are recognized in the Company’s statement of financial
position only when the Company becomes a party to the contractual provisions of the instrument.
Financial assets are derecognized from the statement of financial position when the contractual rights
to receive the cash flows from the financial asset expire, or the assets are transferred and the transfer
qualifies for derecognition in accordance with the derecognition requirements of IAS 39 Financial
Instruments: Recognition and Measurement. Financial liabilities are derecognized from the statement
of financial position only when they are extinguished – i.e. when the obligation specified in the
contract is discharged or cancelled, or expired.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 47
3 Significant accounting policies (continued)
3.12 Financial instruments (continued)
On initial recognition financial assets/(liabilities) are measured at fair value plus, in the case of
financial assets/(liabilities) not reported at fair value through profit or loss, transaction costs, which
are directly attributable to the acquisition or issue of the financial assets/(liabilities).
For the purposes of subsequent measurement, in the current and prior reporting periods the Company
classifies the financial assets and financial liabilities into the following categories: loans and
receivables, and other financial liabilities (other than those, reported at fair value through profit or
loss). The classification under each category depends on the purpose and term of the respective
contract.
Debt and equity instruments issued by the Company, are classified as either financial liabilities or as
equity in accordance with the substance of the contractual arrangements and the definitions of a
financial liability and an equity instrument. An equity instrument is any contract that evidences a
residual interest in the assets of an entity after deducting all of its liabilities.
Financial assets
Financial assets comprise cash on hand and in bank accounts, investments, loans granted, trade and
other receivables and derivative financial instruments.
Financial liabilities
Financial liabilities include trade and other payables, loans received, finance lease liabilities and
derivative financial instruments.
Effective interest rate
The effective interest method is a method of calculating the amortized cost of a financial asset or a
liability (or group of financial assets/liabilities) and of allocating the interest expense or interest
income over the relevant period. The effective interest rate is the rate that exactly discounts the
estimated future cash payments or receipts through the expected life of the financial instrument or,
when appropriate, a shorter period to the net carrying amount of the financial asset or liability.
Impairment of financial assets
As of the date of the financial statements the Company assesses whether there is any objective
evidence for impairment of all financial assets, except for financial assets reported at fair value
through profit or loss. A financial asset is impaired if, and only if, there is objective evidence of
impairment as a result of one or more events that have occurred after the initial recognition of the
asset, resulting in a decrease of the estimated future cash flows. It may not be possible to identify a
single, discrete event, rather than a combined effect of several events that may have caused the
impairment.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 48
3 Significant accounting policies (continued)
3.12 Financial instruments (continued)
Impairment of financial assets (continued)
The Company recognizes impairment of trade and other receivables, whether there is objective
evidence, that the Company would not be able to collect all amounts due at their maturity date. The
Company considers as indications for potential impairment significant financial problems of the
debtor, the probability that the debtor will be a subject to a bankruptcy procedure or non-fulfillment of
the contract terms, as well as payment delay. If any of these indications for impairment occurs, the
impairment loss is calculated as a difference between the carrying amount and the present value of the
expected future cash flows, discounted by the original effective interest rate for similar assets. For
trade receivables that are insured, the impairment equals the difference between the carrying amount
of the receivables and their insurance value. The impairment is recorded by using a separate
impairment account, which is shown as a reduction to receivables in the statement of financial
position and the impairment expenses are stated as Administrative expenses or Distribution expenses
in the income statement depending on the type of the impaired receivable. If a receivable is non-
collectable and there is a recognized impairment loss for it, the receivable is written off by decrease of
the respective allowance account. The recovery of the loss from impairment of trade receivables is
reported in profit or loss and is stated as a decrease of the item, in which the impairment has been
previously recorded.
Derivative financial instruments
The Company uses forward contracts to hedge risks, associated with changes in market prices of the
aluminum on the London Metal Exchange. Such contracts are classified as cash flow hedges as they
hedge the Company’s exposure to variability in cash flows that is attributable to the particular price
risk associated with forecasted sale and purchase transactions. Derivatives are initially recognised at
fair value at the date a derivative contract is entered into and are subsequently remeasured to their fair
value at the end of each reporting period. The fair value of such forward contracts is determined by
reference to the current prices of these contracts on the London Metal Exchange.
The unrealized gain or loss on the forward contracts that are determined to be effective hedge is
recognized through other comprehensive income and is accumulated in a hedging reserve. When a
hedged transaction affects the net profit or loss, the unrealized gain or loss recognized beforehand in a
hedging reserve, is included in the purchase price of the respective acquired inventory.
The Company uses foreign currency swap contracts to hedge its risks associated with the changes in
the foreign currency rates of a long-term debt, denominated in USD. These contracts are classified as
fair value hedges and are initially recognized based on the fair value as of the contract date and
subsequently remeasured to their fair value as of the end of the reporting period. The realized gains
and losses, and the differences in fair value of the foreign currency swap contracts as at the end of the
reporting period are charged in the income statement.
Hedge accounting is discontinued when the hedging instrument expires or is sold, terminated or
exercised.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 49
3 Significant accounting policies (continued)
3.12 Financial instruments (continued)
3.12.1 Cash and cash equivalents
For the purposes of cash flow presentation, cash and cash equivalents represent unrestricted cash on
hand and at banks. For the purposes of the cash flow statement presentation cash receipts from
customers and cash payments to suppliers are presented as gross amounts, including value added tax
(VAT). VAT on purchase of property, plant and equipment and intangible assets is presented as
payments to suppliers in the cash flows from operating activities.
3.12.2 Equity investments and loans granted
The equity investments are non-tradable and are stated at cost less any impairment loss.
Long-term loans granted are initially carried at fair value and subsequently measured at amortized
cost using effective interest rate, which, due to the substance of the loan agreement, coincides with the
interest rate negotiated.
3.12.3 Trade and other receivables
Trade and other receivables are non-derivative financial assets with fixed or determinable payments
that are not quoted in an active market. They are originated when the Company provides cash, goods
for sale or services having no intention to trade them. Receivables are stated at amortized cost,
calculated under the effective interest rate method. For current receivables, which will be settled
within normal credit terms, the amortized cost approximates their nominal value.
3.12.4 Trade and other payables
Trade and other payables incurred as a result of purchases of goods or services, which are not
classified as financial liabilities measured at fair value through profit or loss, are stated in the
statement of financial position at amortized cost, calculated under the effective interest rate method.
For current payables, which will be settled whithin normal credit terms, the amortized cost
approximates their nominal value.
3.12.5 Borrowings and leasing
All borrowings are initially recognized at cost, being the fair value of the consideration received net of
issue costs associated with the borrowing. After initial recognition, interest bearing loans and
borrowings are subsequently measured at amortized cost using the effective interest rate method.
Amortized cost is calculated by taking into account any issue costs, and any discount or premium on
settlement. Gains and losses are recognized in the net profit or loss when the liabilities are
derecognized or impaired, as well as through the amortization process.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 50
3 Significant accounting policies (continued)
3.12 Financial instruments (continued)
3.12.5 Borrowings and leasing (continued)
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the
risks and rewards of ownership to the lessee. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets of the Company at the lower of the present
value of the minimum lease payments and their fair value at the date of acquisition. The
corresponding liability to the lessor is included in the statement of financial position as a finance lease
obligation. Finance costs, which represent the difference between the total leasing commitments and
the fair value of the assets acquired, are charged to the income statement over the term of the relevant
lease so as to produce a constant periodic rate of charge on the remaining balance of the obligations
for each accounting period.
3.12.6 Interest rate risk
Interest rate risk is the risk that the value of the Company’s borrowings will fluctuate due to changes
in market interest rates. Part of the Company’s borrowings are contracted at a floating interest rate and
thus expose the Company to eventual interest rate risk (see also notes 26 and 31).
3.12.7 Credit risk
Financial assets, which potentially expose the Company to credit risk, consist mainly of trade
receivables and advance payments. The Company is primarily exposed to credit risk in the event
where its customers fail to perform their obligations. The Company’s policy is to enter into sales
transactions with customers having favorable credit reputation. In addition, the trade receivables are
secured against future risks by credit limits, which are defined by the insurance company based on
preliminary client research. The Company would receive 90 % of the respective trade receivable as a
compensation, if the clients fail to pay their obligations (see also note 31).
3.12.8 Foreign currency risk
The Company enters into international transactions related mainly to the purchases of raw materials,
sales of finished goods and loans (see note 2.3). Metal hedge operations are completed at cross
currency rates to eliminate the currency risk between the selling price currency and purchase currency
of metals for each order. Therefore, metal hedge operations cover both risk associated with changes in
market prices of the metals on the London Metal Exchange and foreign currency risk (see also notes
24 and 31).
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 51
3 Significant accounting policies (continued)
3.12 Financial instruments (continued)
3.12.9 Liquidity risk
The liquidity risk arises from the time difference in the contracted maturities of the monetary
liabilities and the possibility that the liabilities are not settled on maturity. The Company manages this
risk by using appropriate methods of planning, including providing overdrafts, daily liquidity reports,
short-term and mid-term cash flows forecasts (see also note 31).
3.13 Accruals
Accruals are recognized when the Company has a present obligation as a result of a past event, and it
is probable that the Company will be required to settle that obligation. Accruals are measured at the
management’s best estimate of the expenditure required to settle the obligation at the end of the
reporting period, and are discounted to present value where the effect is material.
3.14 Government grants
Government grants, (financing, government grants), are assistance by the government, government
agencies and similar bodies in the form of transfers of resources to the Company in return for future
compliance with certain conditions relating to the operating activities of the Company. Government
grants may be (i) related to assets and (ii) related to income.
Government grants are recognized when there is reasonable assurance that: (i) the Company will
comply with the conditions attaching to them; and (ii) the grants will be received.
The government grants received by the Company are related to assets and the main condition is to
purchase, produce or acquire in other manner property, plant and equipment. They are presented in
the statement of financial position as deferred income, that are recognized as income on a systematic
and rational basis over the useful life of the acquired assets.
3.15 Critical accounting judgements and key sources of estimation uncertainty
The application of IFRS requires management to apply certain accounting assumptions and
accounting estimates in the preparation of the financial statements, which affect the reported assets,
liabilities and disclosures of contingent assets and liabilities as at the end of the reporting period and
the amounts of revenue and expenses reported during the period. All of them are based on the best
estimate of management as of the date of the preparation of the financial statements. The actual
results may differ from those presented in these financial statements.
The key assumptions concerning the future and other key sources of estimation uncertainty at the end
of the reporting period, that have a significant risk of causing a material adjustment to the carrying
amounts of assets and liabilities within the next financial year, are: the useful lives and fair value of
property, plant and equipment (note 3.7), impairment of assets (note 3.10), fair value of investment
property (note 3.9), fair value of derivatives (note 3.12) and the retirement benefits obligation
(note 3.5).
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 52
4 Revenue
Revenue can be analyzed by markets as follows:
Year ended
December 31,
2014
Year ended
December 31,
2013
Export 272,091 257,047
Domestic 21,444 22,624
Total revenue 293,535 279,671
Revenue can be analyzed by products as follows:
Year ended
December 31,
2014
Year ended
December 31,
2013
Foils 115,746 119,896
Extrusion, pipes and other 99,271 81,583
Strip and sheets 78,518 78,192
Total revenue by products 293,535 279,671
5 Cost of sales
Cost of sales consists of the following:
Year ended
December 31,
2014
Year ended
December 31,
2013
Materials, fuels and electricity 243,724 235,041
Personnel costs 13,825 11,903
Depreciation 11,170 9,111
Other 307 236
Total cost of sales 269,026 256,291
Cost of sales can be analyzed by products as follows:
Year ended
December 31,
2014
Year ended
December 31,
2013
Foils 97,965 99,862
Extrusion, pipes and other 93,045 78,389
Strip and sheets 78,016 78,040
Total cost by products 269,026 256,291
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 53
6 Other income
Other income consists of the following:
Year ended
December 31,
2014
Year ended
December 31,
2013
Sales of materials 6,630 6,027
Insurances indemnities 294 197
Sales of services 248 301
Payables written-off 55 15
Income from rents 48 56
Income from government grants (note 27) 47 -
Other 257 267
Total other income 7,579 6,863
7 Administrative expenses
Administrative expenses consist of the following:
Year ended
December 31,
2014
Year ended
December 31,
2013
Personnel expenses 5,149 5,141
Depreciation and amortization 738 696
Insurance expenses 519 610
Repairs and maintenance 508 356
Security 429 408
Transportation and business travel 421 414
Taxes 299 297
Donations 289 258
Ecology 213 378
Materials 155 142
Communication expenses 124 121
Receivables written-off 150 34
Consulting services 112 106
Fines and tax audits expenses 104 8
Rents 77 101
Other 377 353
Total administrative expenses 9,664 9,423
Expenses on audit of the financial statements of the Company, presented as part of the administrative
expenses for 2014 and 2013 amount to BGN 36 thousand and BGN 39 thousand, respectively.
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 54
8 Distribution expenses
Distribution expenses are, as follows:
Year ended
December 31,
2014
Year ended
December 31,
2013
Transportation 8,546 7,642
Sales commissions 1,357 720
Personnel expenses 735 736
Insurances 353 442
Impairment of trade receivables and claims paid 216 795
Advertisement expenses 178 67
Materials 74 62
Depreciation and amortization 12 11
Other 121 111
Total distribution expenses 11,592 10,586
9 Other expenses
Other expenses are, as follows:
Year ended
December 31,
2014
Year ended
December 31,
2013
Cost of materials and services sold 4,198 4,430
Loss on sales of property, plant and equipment 6 -
Total other expenses 4,204 4,430
10 Operating expenses by nature
The expenses classified by function can be further analyzed by nature, as follows:
Year ended
December 31,
2014
Year ended
December 31,
2013
Materials 242,239 239,073
Personnel costs 19,220 17,993
Depreciation 11,819 9,981
Hired services 13,255 11,843
Other expenses 2,106 2,518
Changes in inventories of finished goods and work in progress 1,986 (4,183)
Capitalized expenses (343) (925)
Total 290,282 276,300
Сost of sales 269,026 256,291
Administrative expenses 9,664 9,423
Distribution expenses 11,592 10,586
Total 290,282 276,300
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 55
11 Exchange rate gain/(loss), net
Exchange rate gain/(loss) net comprises of the following:
Year ended
December 31,
2014
Year ended
December 31,
2013
Exchange rate gain 564 156
Exchange rate loss (494) (338)
Total exchange rate gain/(loss), net 70 (182)
12 Interest expenses, net
Interest expenses, net include the following:
Year ended
December 31,
2014
Year ended
December 31,
2013
Interest expenses on loans, gross (3,882) (3,915)
Less capitalized interest (note 16) 100 1,075
Interest expense on loans (3,782) (2,840)
Interest income 158 150
Financial costs on retirement benefits obligation (42) (51)
Total interest expenses, net (3,666) (2,741)
13 Other financial expenses, net
Year ended
December 31,
2014
Year ended
December 31,
2013
Bank charges (421) (420)
Gain/(loss) from derivative financial instruments 74 (22)
Gain arising from transactions with securities - 53
Total other financial expenses, net (347) (389)
Gains arising from transactions with securities are due to repayments of principal and interest related
to the ZUNK loan (see also note 26).
АLCOMET AD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated
This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 56
14 Income taxes
The deferred tax assets and liabilities accrued, are as follows:
December 31,
2014
December 31,
2013
Deferred tax assets:
Expenses regarding employee benefits 152 185
Receivables written-off 30 71
Accrued and unpaid remunerations 19 47
Derivative financial instruments - 116
Total deferred tax assets 201 419
Deferred tax liabilities:
Derivative financial instruments 83 -
Investment property 248 248
Property, plant and equipment 3,788 4,307
Total deferred tax liabilities 4,119 4,555
Total deferred tax liabilities, net 3,918 4,136
A reconciliation of the effective tax rate is provided in the table below:
Year ended
December 31,
2014
Year ended
December 31,
2013
Profit before taxation 2,685 2,492
Statutory tax rate 10% 10%
Income tax (269) (249) Tax effect of permanent differences (9) (5)
Recorded tax expense (278) (254)
Effective tax rate 10.35% 10.19%
Income tax expense is as follows:
Year ended
December 31,
2014
Year ended
December 31,
2013
Current tax expense on taxable profit (690) (805)
Deferred tax income relating to the origination and reversal of
temporary differences during the current period 412 551
Income tax expense (278) (254)
The deferred tax for 2014 and 2013, charged directly to equity is at the amount of BGN 194 thousand
decrease and BGN 139 thousand increase, r